Skip to main content
Fig. 3 | BMC Medicine

Fig. 3

From: Glucagon-like peptide-1 receptor agonists and diabetic retinopathy: nationwide cohort and Mendelian randomization studies

Fig. 3

Association of GLP-1 RAs and DR using Cox regression in the sensitivity and subgroup analyses. The treatment of GLP-1 RAs was also associated with the risk of DR after excluding the patients with less than 6 months of follow-up. Subgroup analyses indicated GLP-1 RAs were associated with DR in men but not in women. GLP-1 RAs, Glucagon-like peptide-1 receptor agonists; HR, Hazard ratio; CI, Confidence interval; DR, Diabetic retinopathy

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us